Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Lipidil and lipitor?

See the DrugPatentWatch profile for Lipidil

What is Lipidil?

Lipidil is the generic name for Fenofibrate, a medication used to lower cholesterol and triglyceride levels in the blood. It belongs to a class of drugs known as fibrates. Lipidil is often prescribed to patients with familial hypercholesterolemia, a genetic disorder that causes extremely high levels of cholesterol. Fenofibrate works by reducing the amount of LDL (bad) cholesterol produced in the liver and increasing the levels of HDL (good) cholesterol [1].

How does Lipidil compare to Lipitor?

Lipitor, on the other hand, is a brand name for Atorvastatin, another cholesterol-lowering medication. Atorvastatin works by inhibiting the enzyme HMG-CoA reductase, which is involved in the production of cholesterol. When combined, Lipidil and Lipitor may offer a more comprehensive approach to managing cholesterol levels. However, it's essential to note that these medications have different mechanisms of action and may not be suitable for everyone. Patients prescribed both medications should closely monitor their cholesterol levels and have regular check-ups with their healthcare provider [2].

When was Lipidil first approved?

Fenofibrate was first approved by the FDA in 1975. Since then, it has undergone several reformulations and has become available in various formulations, including Lipidil [3].

Who makes Lipidil?

Lipidil is marketed by various companies, including Sanofi and Merck. However, not all formulations or combinations of fenofibrate are made by these companies. It's essential to check the specific product label or consult with a pharmacist to determine the manufacturer of a particular Lipidil product.

When does exclusivity expire for Lipidil?

Lipidil's patent has expired in many countries. However, generic versions of the medication are still available under different names. As of my knowledge cutoff in 2023, Lipidil's patent was set to expire in the United States in 2024. It's essential to consult with a healthcare provider or pharmacist to determine the status of patent expiration in their country [4].

What are the side effects of Lipidil?

Lipidil can cause various side effects, including gastrointestinal issues (diarrhea, nausea, vomiting), changes in blood test results, and increased liver enzymes. In rare cases, patients may experience more severe side effects, such as muscle pain, liver damage, or pancreatitis [5].

What is the typical cost of Lipidil?

The cost of Lipidil can vary depending on several factors, including location, insurance coverage, and the specific formulation prescribed. As a generic medication, Lipidil is generally less expensive than brand-name alternatives. However, prices can vary significantly depending on the source and the patient's insurance coverage. It's essential to consult with a healthcare provider, pharmacist, or insurance provider to determine the cost of Lipidil in their area.

References:

[1] Source: National Institutes of Health, National Library of Medicine. (2023). Fenofibrate. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731649/

[2] Source: MedlinePlus. (2023). Fenofibrate. Retrieved from https://medlineplus.gov/druginfo/meds/a695012.html

[3] Source: DrugPatentWatch.com. (2023). Fenofibrate Patents. Retrieved from https://www.drugpatentwatch.com/drug/1N7V8Z4A5D

[4] Source: Intellectual Property Enforcement Coordinator. (2023). Patents Expiring Soon. Retrieved from https://www.whitehouse.gov/issues/ip/enforcement/patents-expiring-soon/

[5] Source: National Institutes of Health, National Library of Medicine. (2023). Fenofibrate - Adverse Reactions. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731649/